• 4th STRIVE Awards Program Opens to Groups Promoting DMD Advocacy and Care, PTC Announces
  • Catabasis Announces Global Phase 3 Trial of Edasalonexent for DMD Boys
  • New CRISPR Strategy Corrects Wider Range of Mutations Responsible for DMD
  • Bodysuit Will Use Artificial Intelligence to Track Movement in DMD Patients
  • Santhera Making Raxone Available to DMD Patients in US Under Expanded Access Program
  • Protecting Yourself Against This Year’s Flu Virus
  • FDA Grants RMAT Designation to Capricor Cell Therapy for Duchenne
  • Researchers Use Artificial Chromosomes to Deliver Gene Therapy for DMD
  • Skyhawk Secures $8M in Seed Funding to Advance Small Molecule Therapies Targeting RNA
  • NORD Fundraiser Sets 7,000-Mile ‘Bike, Run or Walk’ Goal for 7,000 Rare Diseases
  • European Agency Again Recommends Against Approval of Raxone as DMD Therapy
  • Ezutromid Reduces Muscle Damage in DMD Patients, Interim Data of Phase 2 Trial Shows